← Back
Data updated: Mar 29, 2026
PENN LIFE
Oncology
Generics
PENN LIFE is a generic drug manufacturer focused on Oncology.
2019
Since
4
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
ARSENIC TRIOXIDE 2026-01-30
Labeling
ISOPROTERENOL HYDROCHLORIDE 2025-12-10
ISOPROTERENOL HYDROCHLORIDE 2024-10-03
ISOPROTERENOL HYDROCHLORIDE 2024-08-22
Labeling
THIOTEPA 2024-08-20
ISOPROTERENOL HYDROCHLORIDE 2024-08-06
ARSENIC TRIOXIDE 2024-07-08
Labeling
THIOTEPA 2024-05-30
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (2)
Discontinued (2)
Company Info
- First Approval
- 2019-04-02
- Latest
- 2022-09-20
- Applications
- 4